SCHEMBL1493891

SCHEMBL1493891

O=C(O)c1c(NC(=O)C(F)Cc2ccccc2)csc1-c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ANO1 Q5XXA6 8/20 0.39
MALT1 Q9UDY8 1/20 0.39
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
ADAMTS5 Q9UNA0 2/20 0.38
MMP2 P08253 1/20 0.38
TP53 P04637 3/20 0.38
MDM2 Q00987 3/20 0.38
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
CRHBP P24387 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
CRHR2 Q13324 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ANO2 Q9NQ90 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12756952 0.90 TP53 (0.39) MALT1PPARGPPARAADAMTS5MMP2
SCHEMBL12830434 0.89 ANO1 (0.42) ANO1PPARGPPARAMDM2MEN1
SCHEMBL12756690 0.89 ANO1 (0.42) ANO1PPARGPPARAMDM2MEN1
SCHEMBL1490200 0.89 ANO1 (0.42) ANO1PPARGPPARAMDM2MEN1
SCHEMBL12756682 0.88 PPARG (0.41) ANO1MALT1PPARGPPARAADAMTS5
SCHEMBL12830043 0.87 ANO1 (0.45) ANO1MEN1ALDH1A1LMNAMAPT
SCHEMBL12756673 0.87 MEN1 (0.44) ANO1PPARGPPARAADAMTS5MMP2
SCHEMBL12831276 0.85 ANO1 (0.41) ANO1MEN1ALDH1A1LMNAMAPT
SCHEMBL12756663 0.84 ANO1 (0.38) ANO1MALT1PPARGPPARAADAMTS5
SCHEMBL12830737 0.84 ANO1 (0.47) ANO1MEN1ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-8618307-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-12-31 US disclosed
EP-2477982-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM Calcimedica, Inc. (US) 2012-07-25 EP disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 ANO1 114/4885MALT1 4403/4885PPARG 1551/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 ANO1 114/4885MALT1 4403/4885PPARG 1551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.